← Back to all protocols
14

Alcohol Withdrawal Syndrome (CIWA-Ar guided)Toxicology/Withdrawal

Symptoms

  • Uncomplicated withdrawal: onset 6–8h after last drink, peaks 10–30h, subsides by 40–50h β€” tremor, sweating, fever, nausea/vomiting, anxiety, agitation, insomnia, tachycardia, mild hypertension, Β± hallucinations with otherwise clear sensorium
  • Withdrawal seizures: tonic-clonic, typically 12–48h after cessation; rarely progress to status epilepticus
  • Delirium tremens (DTs): onset 2–5 days (peak day 2–3); auditory/visual hallucinations, severe tremor, disorientation, clouded consciousness, marked autonomic overactivity, HR>100, temp>38.3Β°C β€” medical emergency, 5–20% mortality if unmanaged, 1–5% with appropriate treatment
  • High DT risk: prior severe withdrawal/DTs, HR>100, marked symptoms, intercurrent infection, high temperature

Investigations

  • CIWA-Ar score β€” 10 items: agitation, anxiety, auditory/tactile/visual disturbances, headache, nausea/vomiting, sweating, tremor (each 0–7) + orientation/clouding of sensorium (0–4)
  • Severity: <8 mild, 8–15 moderate, >15 severe (this policy bands pathways as 1–4 White, 5–15 Yellow, 16–25 Orange, >25 Red)
  • Reassess CIWA-Ar + BP/pulse/SpO2/RR at pathway-defined intervals: 4-hourly (White/Yellow), 2-hourly (Orange), 1-hourly (Red)
  • Baseline FBC, LFTs, U&Es; assess nutritional status for Wernicke's risk

Treatment

  • White (1–4): observe, reassess 4-hourly; can stop once ≀4 on 4 consecutive checks
  • Yellow/Mild (5–15): chlordiazepoxide 10mg at each 4-hourly assessment
  • Orange/Moderate (16–25): chlordiazepoxide 20mg at each 2-hourly assessment
  • Red/Severe (>25): chlordiazepoxide 30mg at each 1-hourly assessment; step down once score falls below the next threshold
  • Notify medical staff if patient reaches 240mg chlordiazepoxide/24h or becomes over-sedated
  • Uncontrolled withdrawal (Red pathway, ongoing symptoms despite 1-hourly CIWA + 30mg chlordiazepoxide): senior review (ST3+/consultant) before chlordiazepoxide 30–100mg 2-hourly PRN titrated to CIWA, or diazepam as alternative (2.5mg diazepam β‰ˆ 5mg chlordiazepoxide); add RR to 15-min obs until CIWA<20
  • Delirium tremens: senior review before increased chlordiazepoxide 25–100mg 2-hourly PRN or lorazepam 2–4mg IM 2-hourly; add haloperidol 0.5mg IM 6-hourly if psychosis persists; 15-min obs (incl. RR) until CIWA<20 and for β‰₯1h post-dose
  • Withdrawal seizures β€” medical emergency: rectal diazepam 10mg q5min until controlled, or IV diazepam titrated from 5–10mg; do not start prophylactic anti-epileptics β€” use chlordiazepoxide per pathway for seizure prophylaxis instead
  • Nil-by-mouth: substitute sublingual lorazepam at chlordiazepoxide-equivalent dose (10mg chlordiazepoxide β‰ˆ 0.5mg lorazepam SL); PRN lorazepam SL 0.5–1mg between doses for breakthrough
  • Elderly/liver disease: start at a lower chlordiazepoxide dose; consider shorter-acting oxazepam; established hepatic encephalopathy is a relative contraindication to benzodiazepines β€” senior review first; watch for toxicity (drowsiness, flapping tremor)
  • Poor English/confused/delirious/psychotic patients: CIWA-Ar often unreliable β€” use a fixed reducing chlordiazepoxide regimen instead (e.g. 20mg QID tapering to nil over ~7 days)
  • Wernicke's prophylaxis: low risk β€” thiamine 50mg PO QDS Γ—10 days; low risk+NBM or at-risk (malnourished/weight loss) β€” 1 pair Pabrinex IV once daily Γ—3 days; incipient Wernicke's (confusion/ataxia/ophthalmoplegia) β€” 2 pairs Pabrinex IV TDS Γ—3 days; thiamine 50mg PO OD Γ—10 days after discharge
  • Avoid ward transfer until CIWA ≀10; if transferred at higher score, receiving ward must confirm latest CIWA, current meds and any 1:1 nursing needs
← Back to all protocols